Filter Results:
(142)
Show Results For
- All HBS Web (142)
- Faculty Publications (14)
Show Results For
- All HBS Web (142)
- Faculty Publications (14)
Page 1 of 142
Results →
- 09 Jun 2009
- News
Healthcare Spending v. Quality
- Article
Overturning the ACA's Medicaid Expansion Would Likely Decrease Low-Income, Reproductive-Age Women's Healthcare Spending and Utilization
By: Lucy Chen, Richard G. Frank and Haiden A. Huskamp
In late 2020, the Supreme Court began hearing a case challenging the Affordable Care Act (ACA), which led to coverage gains for many low-income, reproductive-age women. To explore potential implications of a full ACA repeal for this population, we examined gains... View Details
Keywords: Medicaid; Women's Health; Health Insurance; Health Care and Treatment; Gender; Insurance; Poverty; Health Industry; United States
Chen, Lucy, Richard G. Frank, and Haiden A. Huskamp. "Overturning the ACA's Medicaid Expansion Would Likely Decrease Low-Income, Reproductive-Age Women's Healthcare Spending and Utilization." Inquiry 57 (2020).
- November 2011 (Revised August 2012)
- Case
Healthymagination at GE Healthcare Systems
By: Vineet Kumar and V. Kasturi Rangan
Jeff Immelt, the CEO of GE, introduced a new innovation strategy named "healthymagination" in 2009. With cost, quality, and access as its three pillars, healthymagination ensures a strong focus for new product introduction efforts all around GE. But will this focus... View Details
Keywords: Innovation and Invention; Product Marketing; Marketing Strategy; Medical Devices and Supplies Industry; Health Industry
Kumar, Vineet, and V. Kasturi Rangan. "Healthymagination at GE Healthcare Systems." Harvard Business School Case 512-039, November 2011. (Revised August 2012.)
- 20 Oct 2009
- News
On healthcare reform, carrots work better than sticks
- 11 Oct 2011
- Working Paper Summaries
US Healthcare Reform and the Pharmaceutical Industry
- 2018
- Working Paper
Two Hundred Years of Health and Medical Care: The Importance of Medical Care for Life Expectancy Gains
By: Maryaline Catillon, David Cutler and Thomas Getzen
Using two hundred years of national and Massachusetts data on medical care and health, we examine how central medical care is to life expectancy gains. While common theories about medical care cost growth stress growing demand, our analysis highlights the importance of... View Details
Keywords: Mortality; Life Expectancy; Medical Care; Productivity; Public Health; Healthcare Spending; Spending Per Year Of Life Gained; Personal Medicine; Technophysio Evolution; Health; Economics; Health Care and Treatment; Spending; Data and Data Sets; Health Industry
Catillon, Maryaline, David Cutler, and Thomas Getzen. "Two Hundred Years of Health and Medical Care: The Importance of Medical Care for Life Expectancy Gains." NBER Working Paper Series, No. 25330, December 2018.
- February 2021
- Case
New England Baptist Hospital: Getting Paid for Value
By: Robert S. Kaplan, Mary Witkowski, Toby E. Emanuel and Syed S. Shehab
New England Baptist Hospital (NEBH), a national leader in adult orthopedic care, has the lowest rate of complications and 30-day readmissions in New England, but gets paid 30% less for its surgeries than nearby institutions. NEBH introduces, with several large... View Details
Keywords: Healthcare; Healthcare Spending; Healthcare Innovation; Healthcare Industry; Health Care Outcomes; Health Care Delivery; Health Care Reform; Bundled Payments; Health Care and Treatment; Spending; Innovation and Invention; Value Creation; Strategy; Health Industry; North America
Kaplan, Robert S., Mary Witkowski, Toby E. Emanuel, and Syed S. Shehab. "New England Baptist Hospital: Getting Paid for Value." Harvard Business School Case 121-036, February 2021.
- August 2018
- Article
The Impact of the Entry of Biosimilars: Evidence from Europe
By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby... View Details
Keywords: Health Care; Biosimilars; Biologics; Pharmaceutical Competition; Healthcare Spending; Innovation; Health Care and Treatment; Spending; Market Entry and Exit; Competition; Innovation and Invention; Pharmaceutical Industry; United States; Europe
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
- January–February 2022
- Article
Mobilizing the U.S. Military’s TRICARE Program for Value-Based Care: A Report From the Defense Health Board
By: Robert S. Kaplan, Paul R. Schaettle, Vivian S. Lee, Michael D. Parkinson, Gregory H. Gorman and Michael-Anne Browne
The U.S. Military Health System spends about $50 billion annually through its TRICARE health plans to provide care to 9.6 million active duty service members, retirees, and their families. TRICARE, historically, has used the predominant U.S. fee-for-service payment... View Details
Kaplan, Robert S., Paul R. Schaettle, Vivian S. Lee, Michael D. Parkinson, Gregory H. Gorman, and Michael-Anne Browne. "Mobilizing the U.S. Military’s TRICARE Program for Value-Based Care: A Report From the Defense Health Board." Military Medicine 187, nos. 1-2 (January–February 2022): 12–16.
- 01 Feb 2001
- News
The Doctor Is In
ramifications that need to be dealt with as public policy. As for the notion that private-sector efficiency automatically reduces costs, consider that most private health insurance companies spend 10 to 30 percent on administrative... View Details
- October 2022
- Article
It’s Not Just the Prices: Time-Driven Activity-Based Costing for Initiation of Veno-Venous Extracorporeal Membrane Oxygenation at Three International Sites—A Case Review
By: Michael Nurok, Vin Pellegrino, Marc Pineton de Chambrun, Jonathan Warsh, Meredith Young, Erik Dong, Neil Parrish, Syed Shehab, Alain Combes and Robert S. Kaplan
The United States spends more for intensive care units (ICUs) than do other high-income countries. We used time-driven activity-based costing (TDABC) to analyze ICU costs for initiation of extracorporeal membrane oxygenation (ECMO) for respiratory failure to estimate... View Details
Keywords: Healthcare; Cost; Time-Driven ABC; Health Care and Treatment; Cost Management; Activity Based Costing and Management; Health Industry
Nurok, Michael, Vin Pellegrino, Marc Pineton de Chambrun, Jonathan Warsh, Meredith Young, Erik Dong, Neil Parrish, Syed Shehab, Alain Combes, and Robert S. Kaplan. "It’s Not Just the Prices: Time-Driven Activity-Based Costing for Initiation of Veno-Venous Extracorporeal Membrane Oxygenation at Three International Sites—A Case Review." Anesthesia & Analgesia 135, no. 4 (October 2022): 711–718.
- 02 Mar 2007
- What Do You Think?
What Is the Government’s Role in US Health Care?
Summing Up This month's exchange of ideas regarding U.S. healthcare reform ranged far and wide. Some of us were interested primarily in the issue of cost escalation and how to contain it. Others addressed issues of quality. For still... View Details
- 2021
- Government Testimony
How Health Care Consolidation Is Contributing to Higher Prices and Spending, and Reforms That Could Bolster Antitrust Enforcement and Preserve and Promote Competition in Health Care Markets
By: Leemore S. Dafny
Reforms to antitrust law and enforcement can help to address rising healthcare prices and spending. View Details
Keywords: Antitrust Law; Health Care and Treatment; Consolidation; Price; Spending; Cost Management; Governing Rules, Regulations, and Reforms; Competition; United States
Dafny, Leemore S. "How Health Care Consolidation Is Contributing to Higher Prices and Spending, and Reforms That Could Bolster Antitrust Enforcement and Preserve and Promote Competition in Health Care Markets." Government Testimony, Washington, DC, United States, April 2021.
- Profile
Laura Mackay
argument, and to influence and persuade others-critical capabilities for effective leaders. Furthermore, I wanted to be at a place at the forefront of healthcare innovation where I would have access to and be a part of the latest... View Details
- 27 Feb 2020
- Sharpening Your Skills
How Following Best Business Practices Can Improve Health Care
Harvard Business School spends a significant amount of research funds each year on the health care industry, answering questions such as: How can the business of health care be made more efficient? What can a business do to motivate... View Details
- 25 May 2016
- News
The Harvard Medalists of 2016
- Article
The Relationship Between Workplace Stressors and Mortality and Health Costs in the United States
By: Joel Goh, Jeffrey Pfeffer and Stefanos A. Zenios
Even though epidemiological evidence links specific workplace stressors to health outcomes, the aggregate contribution of these factors to overall mortality and health spending in the United States is not known. In this paper, we build a model to estimate the excess... View Details
Goh, Joel, Jeffrey Pfeffer, and Stefanos A. Zenios. "The Relationship Between Workplace Stressors and Mortality and Health Costs in the United States." Management Science 62, no. 2 (February 2016): 608–628.
- 21 Nov 2005
- Research & Ideas
The Geography of Corporate Giving
describe how Thomas worked to influence other large corporations to support his causes—which centered on children's issues such as adoption. Other Columbus-headquartered companies as diverse as The Limited, Bob Evans, and Cardinal View Details
Keywords: by Sean Silverthorne
- 27 Aug 2012
- Research & Ideas
Employee-Suggestion Programs That Work
health care has led her to study nurses, who, as direct care providers, are at the center of the web of supply chains of equipment, supplies, medications, and even physicians. Singer received a grant from the Agency for Healthcare... View Details
Keywords: by Paul Guttry
- 14 Jul 2021
- Blog Post
From Colombia to the District of Columbia: Making an Impact with Paulina Llano (MBA 2022)
herself in Boston at Harvard Business School and is spending the summer interning for a Cambridge-based pharmaceutical and biotech company that has become a household name – Moderna. The contributions Llano will be making to the team and... View Details
Keywords: Health Care